DrugDesign2013: Fragment and Ligand Based Drug Design

DrugDesign2013: Fragment and Ligand Based Drug Design is a conference dedicated to developments in experimental and computational approaches to fragment- and ligand-based drug design, including:

• Fragment binding/selectivity
• Computational chemistry/molecular modeling
• Protein-protein/ligand interaction
• Ligand design and binding
• New screening technologies and their practical applications

Who should Attend

• Academia: Postdoctoral Scientists, Laboratory Heads/Professors, Advanced Graduate Research Students
• Industry: Reseach Directors, SCO, Senior and Junior Researchers, Team Leaders